Home Golden Rules AbbVie Bid for Shire – Offshore Cash And Lessons For Boards

AbbVie Bid for Shire – Offshore Cash And Lessons For Boards

by Nigel Kendall
There is more to good corporate governance and ethical capitalism than a buyer’s deep pocket. A Board must aim to have the most suitable shareholders to achieve the company’s goal. Following Pfizer-AstreZenca, we look at another US bid for a European Pharmaceutical company and the corporate governance lessons from the AbbVie-Shire bid.

Shire, the major healthcare company listed in London, is in the news as the American pharmaceutical company AbbVie attempts to get Shire’s board to recommend its attempt to buy it. This comes hot on the heels of the failed attempt by AbbVie’s bigger US peer, Pfizer, to acquire Shire’s bigger UK peer, AstraZeneca. Since this seems to be part of a rush by cash…

Please register to access this content.

Related Articles

Leave a Comment